多巴胺系统对帕金森病中长期认知障碍的影响:一项探索性研究
Daniel Weintraub1, Marina Picillo2, Hyunkeun Ryan Cho3
1Department of Psychiatry Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA.
Movement disorders clinical practice
|June 19, 2023
概括
多巴胺系统的变化,包括多巴胺载体水平和相当于利沃多巴的每日剂量,预测帕金森病的认知障碍. 这些发现凸显了多巴胺系统在整个疾病进展过程中维持认知健康的关键作用.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 多巴胺系统研究研究
背景情况:
- 在帕金森病 (PD) 中,多巴胺系统和认知障碍 (CI) 之间的关系尚不清楚.
- 研究多巴胺系统生物标志物对于预测PD患者的CI发展至关重要.
研究的目的:
- 探索多巴胺系统相关生物标志物对帕金森病认知障碍发展的影响.
- 为了确定与PD中CI风险增加相关的特定多巴胺系统变化.
主要方法:
- 利用了多个地点的国际前性队列研究的数据,对PD参与者进行了长达7年的跟踪.
- 使用多种措施评估认知障碍,包括MoCA,神经心理测试,MDS-UPDRS认知得分和临床诊断.
- 多巴胺系统通过-123 Ioflupane DAT成像,基因型定型和莱沃多巴每日相当剂量 (LEDD) 进行评估.
主要成果:
- 更高的年龄,男性性别,较低的教育程度,非白人种族,以及增加的抑郁,焦虑和运动分数与CI有关.
- 较低的基线条状多巴胺载体 (DAT) 可用性和较高的LEDD随着时间的推移与PD中CI风险增加有显著的关联.
结论:
- 初步证据表明,多巴胺系统的改变预测了帕金森病中临床相关认知障碍的发展.
- 如果得到证实,这些发现强调了多巴胺系统在PD的整个过程中对认知健康的重要作用.
相关概念视频
Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Alzheimer's Disease: Overview
532
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
532
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K


